Understanding of the quantitative and qualitative changes of AIB1 gene in estrogen-independent and antiestrogen resistant breast cancer cell lines may help in the selection of steroid or non-steroid antiestrogen therapies. The gene discussed is NCOA3; the disease is breast carcinoma.